Your browser doesn't support javascript.
loading
Genetic and transcriptional landscape of plasma cells in POEMS syndrome.
Nagao, Yuhei; Mimura, Naoya; Takeda, June; Yoshida, Kenichi; Shiozawa, Yusuke; Oshima, Motohiko; Aoyama, Kazumasa; Saraya, Atsunori; Koide, Shuhei; Rizq, Ola; Hasegawa, Yoshinori; Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Nishijima, Dai; Isshiki, Yusuke; Kayamori, Kensuke; Kawajiri-Manako, Chika; Oshima-Hasegawa, Nagisa; Tsukamoto, Shokichi; Mitsukawa, Shio; Takeda, Yusuke; Ohwada, Chikako; Takeuchi, Masahiro; Iseki, Tohru; Misawa, Sonoko; Miyano, Satoru; Ohara, Osamu; Yokote, Koutaro; Sakaida, Emiko; Kuwabara, Satoshi; Sanada, Masashi; Iwama, Atsushi; Ogawa, Seishi; Nakaseko, Chiaki.
Afiliación
  • Nagao Y; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Mimura N; Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Takeda J; Department of Hematology, Chiba University Hospital, Chiba, Japan. naoyamimura@chiba-u.jp.
  • Yoshida K; Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan. naoyamimura@chiba-u.jp.
  • Shiozawa Y; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Oshima M; Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
  • Aoyama K; Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Saraya A; Department of Cellular and Molecular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Koide S; Department of Cellular and Molecular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Rizq O; Department of Cellular and Molecular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Hasegawa Y; Department of Cellular and Molecular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Shiraishi Y; Department of Cellular and Molecular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Chiba K; Department of Research and Development, Kazusa DNA Research Institute, Kisarazu, Japan.
  • Tanaka H; Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Nishijima D; Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Isshiki Y; Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kayamori K; Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Kawajiri-Manako C; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Oshima-Hasegawa N; Department of Cellular and Molecular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Tsukamoto S; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Mitsukawa S; Department of Cellular and Molecular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Takeda Y; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Ohwada C; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Takeuchi M; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Iseki T; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Misawa S; Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan.
  • Miyano S; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Ohara O; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Yokote K; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Sakaida E; Department of Hematology, Chiba University Hospital, Chiba, Japan.
  • Kuwabara S; Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan.
  • Sanada M; Department of Neurology, Chiba University Graduate School of Medicine, Chiba, Japan.
  • Iwama A; Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Ogawa S; Department of Technology Development, Kazusa DNA Research Institute, Kisarazu, Japan.
  • Nakaseko C; Department of Clinical Cell Biology and Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
Leukemia ; 33(7): 1723-1735, 2019 07.
Article en En | MEDLINE | ID: mdl-30635632
ABSTRACT
POEMS syndrome is a rare paraneoplastic disease associated with monoclonal plasma cells; however, the pathogenic importance of plasma cells remains unclear. We performed comprehensive genetic analyses of plasma cells in 20 patients with POEMS syndrome. Whole exome sequencing was performed in 11 cases and found a total of 308 somatic mutations in 285 genes. Targeted sequencing was performed in all 20 cases and identified 20 mutations in 7 recurrently mutated genes, namely KLHL6, LTB, EHD1, EML4, HEPHL1, HIPK1, and PCDH10. None of the driver gene mutations frequently found in multiple myeloma (MM) such as NRAS, KRAS, BRAF, and TP53 was detected. Copy number analysis showed chromosomal abnormalities shared with monoclonal gammopathy of undetermined significance (MGUS), suggesting a partial overlap in the early development of MGUS and POEMS syndrome. RNA sequencing revealed a transcription profile specific to POEMS syndrome when compared with normal plasma cells, MGUS and MM. Unexpectedly, disease-specific VEGFA expression was not increased in POEMS syndrome. Our study illustrates that the genetic and transcriptional profiles of plasma cells in POEMS syndrome are distinct from MM and MGUS, indicating unique function of clonal plasma cells in its pathogenesis.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Plasmáticas / Biomarcadores de Tumor / Síndrome POEMS / Perfilación de la Expresión Génica / Mutación / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Células Plasmáticas / Biomarcadores de Tumor / Síndrome POEMS / Perfilación de la Expresión Génica / Mutación / Recurrencia Local de Neoplasia Tipo de estudio: Prognostic_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Japón
...